Login / Signup

Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.

Yasui-Furukori NorioHiroyuki MuraokaNaomi HasegawaShinichiro OchiShusuke NumataHikaru HoriAkitoyo HishimotoToshiaki OnitsukaKazutaka OhiNaoki HashimotoTatsuya NagasawaYoshikazu TakaesuTakahiko InagakiHiromi TagataTakashi TsuboiChika KubotaRyuji FurihataJun-Ichi IgaHitoshi IidaKenichiro MiuraJunya MatsumotoHisashi YamadaKoichiro WatanabeKen InadaKazutaka ShimodaRyota Hashimoto
Published in: Neuropsychopharmacology reports (2021)
As a preliminary problem for the use of clozapine, in Japan, the examination rate of TRS varies, and there are many facilities that typically do not consider the possibility of TRS; this trend leads to a low rate of clozapine use. Clearly, further clinician training is needed for the early detection and appropriate management of TRS that includes an explanation of TRS and how to introduce clozapine therapy to patients and their families.
Keyphrases
  • end stage renal disease
  • healthcare
  • primary care
  • ejection fraction
  • newly diagnosed
  • bipolar disorder
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • replacement therapy